These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 29984720)
1. Evaluation of sociodemographic, clinical, and laboratory markers of sickle leg ulcers among young nigerians at a tertiary health institution. Olatunya OS; Albuquerque DM; Adekile AD; Costa FF Niger J Clin Pract; 2018 Jul; 21(7):882-887. PubMed ID: 29984720 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of clinical and laboratory correlates of sickle leg ulcers. Madu AJ; Ubesie A; Madu KA; Okwor B; Anigbo C Wound Repair Regen; 2013; 21(6):808-12. PubMed ID: 24134724 [TBL] [Abstract][Full Text] [Related]
3. Phenotypic characterisation and associations of leg ulcers in adult sickle cell patients. Madu A; Madu K; Anigbogu I; Ugwu AO; Okwulehie VA; Ololo U; Ugwu C; Chikezie K Wound Repair Regen; 2022 Jan; 30(1):126-131. PubMed ID: 34738694 [TBL] [Abstract][Full Text] [Related]
4. Low nitric oxide level is implicated in sickle cell disease and its complications in Ghana. Antwi-Boasiako C; Campbell AD Vasc Health Risk Manag; 2018; 14():199-204. PubMed ID: 30233199 [TBL] [Abstract][Full Text] [Related]
5. Variations and characteristics of the various clinical phenotypes in a cohort of Nigerian sickle cell patients. Duru A; Madu AJ; Okoye H; Nonyelu C; Obodo O; Okereke K; Madu K Hematology; 2021 Dec; 26(1):684-690. PubMed ID: 34493173 [TBL] [Abstract][Full Text] [Related]
6. Leg Ulcers in Sickle Cell Disease: A Multifactorial Analysis Highlights the Hemolytic Profile. Santos EDC; Santana PVB; Jesus LLS; Melo GIV; Yahouédéhou SCMA; Guarda CCD; Santiago RP; Fiuza LM; Carvalho SP; Santos LOD; Adorno EV; Aleluia ACM; Luiz LCGC; Fonseca TCC; Gonçalves MS; Aleluia MM Hematol Rep; 2023 Feb; 15(1):119-129. PubMed ID: 36810556 [TBL] [Abstract][Full Text] [Related]
7. Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in Africa. Dubert M; Elion J; Tolo A; Diallo DA; Diop S; Diagne I; Sanogo I; Belinga S; Guifo O; Wamba G; Ngo Sack F; Boidy K; Kamara I; Traore Y; Diakite CO; Gbonon V; Faye BF; Seck M; Deme Ly I; Chelo D; N'Guetta R; Diop IB; Gaye B; Jouven X; Ranque B Blood; 2017 Nov; 130(20):2215-2223. PubMed ID: 28931524 [TBL] [Abstract][Full Text] [Related]
8. Sickle cell disease clinical phenotypes in Nigeria: A preliminary analysis of the Sickle Pan Africa Research Consortium Nigeria database. Isa H; Adegoke S; Madu A; Hassan AA; Ohiaeri C; Chianumba R; Brown B; Okocha E; Ugwu N; Diaku-Akinwumi I; Adeyemo T; Kuliya-Gwarzo A; Dogara L; Lawal H; Tanko Y; Ladu A; Kangiwa U; Ekwem L; Oniyangi S; Wakama T; Umoru D; Olanrewaju O; Akinola N; Nnebe-Agumadu U; Asala S; Adekile A; Olaniyi J; Sangeda R; Sickle Africa Data Coordinating Center SADaCC ; Nnodu O Blood Cells Mol Dis; 2020 Sep; 84():102438. PubMed ID: 32504882 [TBL] [Abstract][Full Text] [Related]
9. Severity of Brazilian sickle cell disease patients: severity scores and feasibility of the Bayesian network model use. Belini Junior E; Silva DG; Torres Lde S; Okumura JV; Lobo CL; Bonini-Domingos CR Blood Cells Mol Dis; 2015 Apr; 54(4):321-7. PubMed ID: 25842370 [TBL] [Abstract][Full Text] [Related]
10. A Description of the Hemolytic Component in Sickle Leg Ulcer: The Role of Circulating miR-199a-5p, miR-144, and miR-126. Santos EDC; Melo GIV; Santana PVB; Quadros IGS; Yahouédéhou SCMA; Guarda CCD; Santiago RP; Fiuza LM; Carvalho SP; Adorno EV; Kaneto CM; Fonseca TCC; Goncalves MS; Aleluia MM Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204817 [TBL] [Abstract][Full Text] [Related]
11. Priapism in homozygous sickle cell patients: important clinical and laboratory associations. Madu AJ; Ubesie A; Ocheni S; Chinawa J; Madu KA; Ibegbulam OG; Nonyelu C; Eze A Med Princ Pract; 2014; 23(3):259-63. PubMed ID: 24685837 [TBL] [Abstract][Full Text] [Related]
12. A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis. Antwi-Boasiako C; Andemariam B; Colombatti R; Asare EV; Strunk C; Piccone CM; Manwani D; Boruchov D; Farooq F; Urbonya R; Wilson S; Boatemaa GD; Perrotta S; Sainati L; Rivers A; Rao S; Zempsky W; Ekem I; Sey F; Segbefia C; Inusa B; Tartaglione I; Campbell AD Ann Hematol; 2020 Sep; 99(9):2073-2079. PubMed ID: 32377816 [TBL] [Abstract][Full Text] [Related]
13. Sickle cell disease clinical phenotypes in children from South-Western, Nigeria. Adegoke SA; Adeodu OO; Adekile AD Niger J Clin Pract; 2015; 18(1):95-101. PubMed ID: 25511352 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria. Aliyu ZY; Gordeuk V; Sachdev V; Babadoko A; Mamman AI; Akpanpe P; Attah E; Suleiman Y; Aliyu N; Yusuf J; Mendelsohn L; Kato GJ; Gladwin MT Am J Hematol; 2008 Jun; 83(6):485-90. PubMed ID: 18306362 [TBL] [Abstract][Full Text] [Related]
15. Chronic leg ulcers in sickle cell disease: experience in Ibadan, Nigeria. Durosinmi MA; Gevao SM; Esan GJ Afr J Med Med Sci; 1991 Mar; 20(1):11-4. PubMed ID: 1905464 [TBL] [Abstract][Full Text] [Related]
16. Hydroxyurea and fetal hemoglobin effect on leg ulcers in patients with sickle cell disease. Tolu SS; Crouch A; Choi J; Gao Q; Reyes-Gil M; Ogu UO; Vinces G; Minniti CP Ann Hematol; 2022 Mar; 101(3):541-548. PubMed ID: 35039901 [TBL] [Abstract][Full Text] [Related]
17. Sickle cell leg ulcers: a frequently disabling complication and a marker of severity. Halabi-Tawil M; Lionnet F; Girot R; Bachmeyer C; Lévy PP; Aractingi S Br J Dermatol; 2008 Feb; 158(2):339-44. PubMed ID: 18047512 [TBL] [Abstract][Full Text] [Related]
18. The effect of the coinheritance of Glucose-6-phosphate dehydrogenase deficiency on the severity of sickle cell disease. Fasola FA; Fowodu FO; Shokunbi WA; Kotila TR Niger Postgrad Med J; 2019; 26(2):118-122. PubMed ID: 31187752 [TBL] [Abstract][Full Text] [Related]
19. Intima-media thickness of the common femoral artery as a marker of leg ulceration in sickle cell disease patients. Ayoola OO; Bolarinwa RA; Onakpoya UU; Adedeji TA; Onwuka CC; Idowu BM Blood Adv; 2018 Nov; 2(22):3112-3117. PubMed ID: 30455360 [TBL] [Abstract][Full Text] [Related]
20. Leg ulcers in sickle cell disease: current patterns and practices. Delaney KM; Axelrod KC; Buscetta A; Hassell KL; Adams-Graves PE; Seamon C; Kato GJ; Minniti CP Hemoglobin; 2013; 37(4):325-32. PubMed ID: 23600469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]